Medium Risk

Unichem Laboratories Limited

Drugs and Pharmaceuticals

CIN: L99999MH1962PLC012451 FY: - Revenue: ₹1,735.7 Cr
5.4
ESG Risk
Score /10
Compliance RiskEpr ExposureGhg Intensity

Risk Breakdown

GHG Intensity
5.0
Water Intensity
5.0
Waste Intensity
1.4
EPR Exposure
6.5
Compliance Risk
10.0
HR Risk
3.0
Governance Risk
5.0

Financial Exposure

Est. Compliance Cost₹3–10 crore
EPR ApplicableUnknown
Scope 1 Emissions— tCO2e
Scope 2 Emissions— tCO2e
Water Withdrawal— m³
Waste Generated7,383.6 T

Governance

Anti-Corruption PolicyYes
Conflict of Interest PolicyUnknown
BRSR AssuranceNone
Assurance Provider

Double Materiality

Financial Materiality5.4
Impact Materiality4.7
QuadrantFinancially Material

Supply Chain

MSME Sourcing0.1%
Lifecycle AssessmentNo
Product ReclaimYes

Material Risks

e-waste

ESG Targets & Commitments

TopicTarget / MetricStatus
Human Rights in Supply Chain HR clauses in all contracts Commitment

AI Risk Summary

Unichem Laboratories faces a critical compliance exposure of ₹3–10 crore in estimated remediation costs, driven by a maximum compliance risk score of 10.0/10 under SEBI BRSR Core Expansion requirements—with non-compliance risking enforcement action and potential delisting for a listed pharmaceutical entity. The company's Extended Producer Responsibility (EPR) exposure score of 6.5/10 indicates uncertain pharmaceutical waste management liability under Schedule IV of the Plastic Waste Management Rules; clarification of EPR applicability and cost quantification is urgent to avoid regulatory penalties. Although Scope 1 and 2 emissions data are absent, the 5.0/10 GHG and water intensity scores suggest material operational emissions that must be measured and disclosed to satisfy BRSR P6 thresholds; missing carbon accounting leaves the company exposed to India's CCTS framework (₹600–900/tonne) should future obligations apply. Immediate action required: formal BRSR compliance audit, EPR scope clarification, and establishment of emissions accounting systems to de-risk ₹3–10 crore liability and regulatory standing

Source: Unichem Laboratories Limited BRSR Filing, FY -. Derived from the company's own public disclosures. Not investment advice or a regulatory determination.

← Back to ESG Quotient Dashboard Share on LinkedIn Browse all companies →